Eddy Lee was appointed to the Board on 17 January 2008 and is a member of the Nominating Committee. As Group Chairman & CEO, he is responsible for the development and execution of the Group’s strategic vision and expansion plans.
Eddy possesses more than 25 years of international business experience, having worked as Senior Vice President of Resorts World (Genting Group) in Malaysia, Chief Executive of CDL Hotels International Limited (Hong Leong Group) in Hong Kong, President & Chief Executive of Star Cruises PLC (Genting Group) in Singapore and more recently, as Managing Director & Chief Executive of Amcom Telecommunications Limited in Australia.
Eddy is highly regarded as a professional start-up specialist with a very impressive track record in developing companies that have experienced outstanding brand recognition and tremendous growth. He was involved in the successful start-ups of the Burswood Resort Hotel in Perth and Star Cruises PLC in Singapore, and is perhaps best known for successfully introducing, developing and transforming the cruise industry in Asia into a multi-million dollar business today.
Eddy holds a Bachelor of Business degree from Curtin University.
Albert Ho was appointed to the Board on 1 March 2013 and serves as a member of the Audit and Remuneration Committees.
Albert is currently a director of Centrum Capital, an investment and asset management firm. He has previously worked at international banks and multinational corporations, and possesses more than 25 years of experience in the areas of corporate development, finance and investment banking.
Albert is also an independent director of Riverstone Holdings Limited, a company listed on the Singapore Exchange, and is a member of its Audit and Remuneration Committees. He is also a Councillor of CPA Australia’s Singapore Division and the Deputy Chairman of CPA Australia’s Corporate-SME Committee in Singapore.
Albert holds a Bachelor of Commerce degree from the Australian National University and is a Fellow Certified Practising Accountant with CPA Australia.
Low Weng Keong was appointed to the Board on 18 June 2015 and serves as the Chairman of the Audit Committee and a member of the Nominating and Remuneration Committees. He is an independent director of UOL Group Limited and Riverstone Holdings Limited, both listed on the Singapore Exchange.
Weng Keong was a former country managing partner of Ernst & Young Singapore and a former Global Chairman and President of CPA Australia. He is a Director of the Confederation of Asian and Pacific Accountants and the Singapore Institute of Accredited Tax Practitioners. He is also a member of the Board of Trustees of the NTUC Education and Training Fund.
Weng Keong is a Life Member of CPA Australia, Fellow Chartered Accountant (UK), Fellow Chartered Accountant (Singapore), life member of CPA (Australia), Chartered Tax Advisor (UK) and an Accredited Tax Advisor (Singapore).
Mr. Davies was appointed to the Board on 2 December 2019 and serves as the Lead Independent Director, the Chairman of Remuneration Committee, and a member of Audit and Nominating Committees. Mr. Davies is the Non-Executive Chairman of Nueren Pharmaceuticals Limited listed on the Australian Stock Exchange.
Mr. Davies has held executive management roles in the Australian and New Zealand healthcare industry for over twenty-five years having performed successfully in senior roles across many industry sectors including pharmacy, primary care, pharmaceutical and consumer products. During his ten year period as Chief Executive Officer of EBOS Group Limited (and previously Symbion), the enterprise value of the group achieved compound annual growth in enterprise value of +20% (from circa A$450M to in excess of A$3.1B). He is also a director on other non-listed corporate boards and provides strategic advice to a range of healthcare businesses and investors.
Mr Davies holds Bachelor of Economics from University of Adelaide and Master of Business Administration from Australian Graduate School of Management.
Claudia Teo was appointed to the Board on 18 June 2015 and serves as Chairman of the Nominating Committee and a member of the Audit and Remuneration Committees. Ms Teo currently heads the Corporate and Financial Services practice group in Eversheds Harry Elias LLP (“EHE”). She possesses over 20 years of experience in corporate and securities laws, advising on landmark, cross- border, merger and acquisition transactions in addition to initial public offerings and compliance issues on the Singapore Stock Exchange. Some of her complex deal structures have focused on various industries including healthcare and pharmaceuticals, fintech, natural resources, lifestyle and real estate and construction.
Claudia’s key practice areas at EHE are corporate finance as well as merger and acquisition transactions throughout Asia. She was recommended in the 2016 edition of The Legal 500 as well as in the 2014 edition of Asialaw’s Leading Publication. She is also a director and member of the Investment/Governance & Risk Committee of Ren Ci Hospital & Medicare Centre, a Singapore charity healthcare institution.
Claudia completed her Bachelor of Laws at University of Manchester. She was called to the Singapore Bar and is dually qualified as a barrister and a solicitor of England and Wales and is admitted to the Rolls of Solicitors of Hong Kong.